Shared Decision Making in PTSD Treatment
This study is looking at how involving you in decisions about your treatment for Post-Traumatic Stress Disorder (PTSD) affects how well the treatment works. Researchers want to see if using a "Shared Decision Making" approach helps active duty military service members stay engaged in therapy and achieve better results. You would work with your therapist to choose one of three behavioral therapies: Prolonged Exposure (PE) therapy, Cognitive Processing Therapy (CPT), or Written Exposure Therapy (WET). The study is for active duty military service members aged 18 or older who have been diagnosed with PTSD. The study will measure if you start and complete treatment, and your preference for a specific treatment type.
- Study design
- This is an interventional study planning to enroll 200 participants. It will use a partially randomized preference trial design.
- What's involved
- You would participate in a Shared Decision Making session, then receive one of three PTSD therapies for up to 24 sessions (PE or CPT) or up to 7 sessions (WET). Treatment completion will be measured between 2 and 7 months.
- Compensation
- Not stated in the trial record.
- Follow-up
- Treatment completion will be measured between 2 and 7 months after starting treatment, depending on the therapy chosen and your progress.
AI-generated from the public study record. Only the study team can confirm whether you're eligible — confirm details with them before making decisions.
Shared Decision Making in PTSD Treatment
At a glance
Conditions
Where it's being run
2 sites across 1 statesStudy leadership
- Vanessa Jacoby, PhD · PRINCIPAL_INVESTIGATOR · The University of Texas Health Science Center at San Antonio
- Alan L Peterson, PhD · PRINCIPAL_INVESTIGATOR · The University of Texas Health Science Center at San Antonio
Who to contact
Opens a ready-to-send draft in your own email app — review before sending.
What this trial measures
- Completion of treatment initiationBaseline to Treatment Session 1 (approximately 2 weeks)
Percentage of participants initiate and complete at least one session of evidence-based Posttraumatic Stress Disorder (PTSD) treatment
- Completion of all Treatment sessionsBaseline to Posttreatment (between 2 months and 7 months, depending on treatment selected and speed of progress)
The percentage of participants who complete all manualized protocol sessions (i.e., 10 PE sessions, 12 CPT sessions, or 5 WET sessions) or (2) complete treatment early because they have achieved their treatment goals. This will be defined as achieving a 10 point reduction in on the PCL-5 and scoring below the diagnostic cutoff (a PCL- 5 score of ≤ 30), as well as the therapist and patient agreeing that treatment relevant goals have been met.
- Preference for type of treatmentMeasured at Pre-Treatment Shared Decision-Making Session
Measured on a Likert Scale from 0= no preference to 10= extremely high preference
- Posttraumatic Stress Disorder Checklist (PCL-5)Baseline to 1 month follow up assessment (between 2 months and 7 months, depending on treatment selected and speed of progress)
The PCL-5 is a 20-item self-report measure, selected for its dimensional sensitivity, with higher scores reflecting greater PTSD severity. Scoring is based on how much the patient has been bothered by the symptoms in the past month on a scale from "0 = not at all" to "4 = extremely. Scores range from 0-80 with a higher score indicating more severe PTSD.